Cargando…
Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The International AIDS Society
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112995/ http://dx.doi.org/10.1186/1758-2652-13-S4-P210 |
| _version_ | 1782205864325677056 |
|---|---|
| author | Nelson, M Amaya, G Clumeck, N Arns Da Cunha, C Jayaweera, D Junod, P Taisheng, L Tebas, P Stevens, M Buelens, A Vanveggel, S Boven, K |
| author_facet | Nelson, M Amaya, G Clumeck, N Arns Da Cunha, C Jayaweera, D Junod, P Taisheng, L Tebas, P Stevens, M Buelens, A Vanveggel, S Boven, K |
| author_sort | Nelson, M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3112995 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | The International AIDS Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31129952011-06-13 Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials Nelson, M Amaya, G Clumeck, N Arns Da Cunha, C Jayaweera, D Junod, P Taisheng, L Tebas, P Stevens, M Buelens, A Vanveggel, S Boven, K J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3112995/ http://dx.doi.org/10.1186/1758-2652-13-S4-P210 Text en Copyright ©2010 Nelson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Nelson, M Amaya, G Clumeck, N Arns Da Cunha, C Jayaweera, D Junod, P Taisheng, L Tebas, P Stevens, M Buelens, A Vanveggel, S Boven, K Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials |
| title | Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials |
| title_full | Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials |
| title_fullStr | Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials |
| title_full_unstemmed | Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials |
| title_short | Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials |
| title_sort | efficacy and safety of tmc278 in treatment-naïve, hiv-1-infected patients with hbv/hcv co-infection enrolled in the phase iii echo and thrive trials |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112995/ http://dx.doi.org/10.1186/1758-2652-13-S4-P210 |
| work_keys_str_mv | AT nelsonm efficacyandsafetyoftmc278intreatmentnaivehiv1infectedpatientswithhbvhcvcoinfectionenrolledinthephaseiiiechoandthrivetrials AT amayag efficacyandsafetyoftmc278intreatmentnaivehiv1infectedpatientswithhbvhcvcoinfectionenrolledinthephaseiiiechoandthrivetrials AT clumeckn efficacyandsafetyoftmc278intreatmentnaivehiv1infectedpatientswithhbvhcvcoinfectionenrolledinthephaseiiiechoandthrivetrials AT arnsdacunhac efficacyandsafetyoftmc278intreatmentnaivehiv1infectedpatientswithhbvhcvcoinfectionenrolledinthephaseiiiechoandthrivetrials AT jayaweerad efficacyandsafetyoftmc278intreatmentnaivehiv1infectedpatientswithhbvhcvcoinfectionenrolledinthephaseiiiechoandthrivetrials AT junodp efficacyandsafetyoftmc278intreatmentnaivehiv1infectedpatientswithhbvhcvcoinfectionenrolledinthephaseiiiechoandthrivetrials AT taishengl efficacyandsafetyoftmc278intreatmentnaivehiv1infectedpatientswithhbvhcvcoinfectionenrolledinthephaseiiiechoandthrivetrials AT tebasp efficacyandsafetyoftmc278intreatmentnaivehiv1infectedpatientswithhbvhcvcoinfectionenrolledinthephaseiiiechoandthrivetrials AT stevensm efficacyandsafetyoftmc278intreatmentnaivehiv1infectedpatientswithhbvhcvcoinfectionenrolledinthephaseiiiechoandthrivetrials AT buelensa efficacyandsafetyoftmc278intreatmentnaivehiv1infectedpatientswithhbvhcvcoinfectionenrolledinthephaseiiiechoandthrivetrials AT vanveggels efficacyandsafetyoftmc278intreatmentnaivehiv1infectedpatientswithhbvhcvcoinfectionenrolledinthephaseiiiechoandthrivetrials AT bovenk efficacyandsafetyoftmc278intreatmentnaivehiv1infectedpatientswithhbvhcvcoinfectionenrolledinthephaseiiiechoandthrivetrials |